Figure 3From: Cancer therapy and cardiotoxicity: The need of serial Doppler echocardiographyDoppler transmitral inflow pattern in a 58-year old female patient with acute myeloid leukemia before treatment (upper panel) and after DNR (= daunorubicine) 50 mg/m2, VP16 (= etoposide) 50 mg/m2, ARA-C (= cytarabine) 30 mg/m2 (lower panel). Transmitral pattern, normal before treatment (transmitral E/A ratio = 1.12, deceleration time = 172 ms), shifts to pattern of LV abnormal relaxation, corresponding to grade I of LV diastolic dysfunction (E/A ratio = 0.70, deceleration time = 230 ms) after CT.Back to article page